Engineering LNPs for Next Generation Vaccines & Therapeutics
- Rational design approaches are applied for tailoring lipid and LNP architecture
- Tailored formulations with tunable immunogenicity and precise targeting specificity are provided
- Formulations allow for repeat dosing in therapeutic settings
- Improved safety and reduced reactogenicity were demonstrated in a clinical study